Orchid Pharma Ltd — Quarterly Results & Earnings

₹482.45

-5.52%

Profit Growth YoY-121.00%Latest quarter

Sales Growth YoY-13.10%Latest quarter

Sales CAGR 5Y13.76%5 year compound

Profit CAGR 5Y22.53%5 year compound

📋

Quarterly Performance

YoY Profit Growth-121.00%

🔴 Significant decline

YoY Sales Growth-13.10%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

11.64%

EPS Growth 5Y

21.18%

Interest Coverage

Higher = safer debt servicing

4.53

ROE

8.21%

ROCE

8.07%

💡

Growth Analysis

Orchid Pharma Ltd reported YoY profit growth of -121.00% and revenue growth of -13.10% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 13.76% and profits at 22.53% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Orchid Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.